"Medical Marijuana: 76% Of Doctors Would Prescribe
Post# of 36728
Posted On: 12/13/2013 4:44:22 PM
"Medical Marijuana: 76% Of Doctors Would Prescribe It, Poll Finds"
"Three out of four doctors would prescribe marijuana to a patient who was experiencing pain from cancer, according to the results of a poll published in the New England Journal of Medicine."
Very pleased both low and high dose Dharmanol™ are ready for California distribution to collectives and dispensaries. There was a thought that just low dose would go first, but this news is much more than doubly good. There are very important media looking at this story. The high dose Dharmanol™ for cancer is the dramatic play.
PR
"Dharmanol™ (pronounced DAR-mah-nol) will be available in two forms: low-dose, non-psychoactive tablets and high-doses directed to cancer."
"At the opposite end of the spectrum is using Dharmanol™ for cancer. Very large doses can be taken daily with no psychoactive effects. On observing the spectacular results that patients are receiving with standard Simpson therapy, most scientists studying cannabis medicine agree that if the dose could be increased ten or a hundred times, its already substantial efficacy will be greatly increased. Now this is possible thanks to the removal of the 'high' from the cannabinoids in the production of Dharmanol™."
"The low-dose, non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response. Much research has shown that there is substantial medicinal benefit in 'stimulating' a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should."
"Three out of four doctors would prescribe marijuana to a patient who was experiencing pain from cancer, according to the results of a poll published in the New England Journal of Medicine."
Very pleased both low and high dose Dharmanol™ are ready for California distribution to collectives and dispensaries. There was a thought that just low dose would go first, but this news is much more than doubly good. There are very important media looking at this story. The high dose Dharmanol™ for cancer is the dramatic play.
PR
"Dharmanol™ (pronounced DAR-mah-nol) will be available in two forms: low-dose, non-psychoactive tablets and high-doses directed to cancer."
"At the opposite end of the spectrum is using Dharmanol™ for cancer. Very large doses can be taken daily with no psychoactive effects. On observing the spectacular results that patients are receiving with standard Simpson therapy, most scientists studying cannabis medicine agree that if the dose could be increased ten or a hundred times, its already substantial efficacy will be greatly increased. Now this is possible thanks to the removal of the 'high' from the cannabinoids in the production of Dharmanol™."
"The low-dose, non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response. Much research has shown that there is substantial medicinal benefit in 'stimulating' a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should."
(0)
(0)SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼